{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:12:21Z","timestamp":1790305941669,"version":"4.1.0"},"reference-count":41,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:sec>\n<jats:title>OBJECTIVE<\/jats:title>\n<jats:p>Moyamoya disease (MMD) is a chronic steno-occlusive cerebrovascular disease and features the formation of hazy collateral vessels at the base of the brain. Angiopoietin (Ang)\u20131 and -2, their receptor Tie-2, and vascular endothelial growth factor (VEGF) that regulate angiogenesis might be important in MMD pathophysiology and postoperative collateral formation. The goal of this study was to determine whether levels of these angiogenic factors could predict collateralization in patients with MMD.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>METHODS<\/jats:title>\n<jats:p>A total of 196 patients with MMD and 57 with atherosclerotic cerebrovascular disease serving as controls were enrolled. Ang-1, Ang-2, Tie-2, and VEGF mRNA levels were analyzed in middle cerebral artery (MCA) arterial wall specimens by using real-time quantitative polymerase chain reaction. MCA and peripheral plasma concentrations of Ang-1, Ang-2, soluble Tie-2 (sTie-2), and VEGF were examined by enzyme-linked immunosorbent assay. Cerebral arteriography was performed 6 months after bypass surgery to assess the postoperative collateralization.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>RESULTS<\/jats:title>\n<jats:p>In MCA specimens, patients with MMD exhibited higher expression levels of Ang-1 and Ang-2 but lowered VEGF expression. The patients with MMD had significantly higher concentrations of Ang-1 and Ang-2 but lower levels of VEGF in MCA plasma. Peripheral plasma concentrations of these growth factors were not changed. MCA and peripheral plasma sTie-2 levels were both reduced in patients with MMD. The 6-month follow-up showed that patients with good collateral formation had lower sTie-2 levels in both MCA and peripheral plasma. Furthermore, the Suzuki stage and peripheral plasma sTie-2 level were significantly correlated with good postoperative collateral formation on multivariate analysis.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>CONCLUSIONS<\/jats:title>\n<jats:p>Ang-1, Ang-2, Tie-2, and VEGF are involved in MMD pathogenesis. The peripheral plasma level of sTie-2 can differentiate MMD from atherosclerotic cerebrovascular disease and serve as a novel biomarker to predict postoperative collateral formation.<\/jats:p>\n<\/jats:sec>","DOI":"10.3171\/2023.4.jns23479","type":"journal-article","created":{"date-parts":[[2023,6,18]],"date-time":"2023-06-18T09:31:07Z","timestamp":1687080667000},"page":"1705-1714","source":"Crossref","is-referenced-by-count":9,"title":["Assessment of plasma soluble Tie-2 level to distinguish moyamoya disease from atherosclerotic cerebrovascular disease and predict postoperative neovascularization"],"prefix":"10.3171","volume":"139","author":[{"given":"Tongyu","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Zhongnan Hospital of Wuhan University; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Zhongnan Hospital of Wuhan University; and"},{"name":"Brain Research Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Zhongnan Hospital of Wuhan University; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Zhongnan Hospital of Wuhan University; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangxiang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Zhongnan Hospital of Wuhan University; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Du","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Zhongnan Hospital of Wuhan University; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Zhongnan Hospital of Wuhan University; and"},{"name":"Brain Research Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jincao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Zhongnan Hospital of Wuhan University; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"12","key":"b1","series-title":"N Engl J Med","first-page":"1226","article-title":"Moyamoya disease and moyamoya syndrome","volume":"360","author":"Scott RM","year":"2009","unstructured":"Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360(12):1226\u20131237."},{"issue":"1","key":"b2","series-title":"J Stroke","first-page":"12","article-title":"The pathophysiology of moyamoya disease: an update","volume":"18","author":"Bang OY","year":"2016","unstructured":"Bang OY, Fujimura M, Kim SK. The pathophysiology of moyamoya disease: an update. J Stroke. 2016;18(1):12\u201320."},{"issue":"5","key":"b3","series-title":"J Neurosurg","first-page":"1048","article-title":"Outcome in adult patients with hemorrhagic moyamoya disease after combined extracranial-intracranial bypass","volume":"121","author":"Jiang H","year":"2014","unstructured":"Jiang H, Ni W, Xu B,  Outcome in adult patients with hemorrhagic moyamoya disease after combined extracranial-intracranial bypass. J Neurosurg. 2014;121(5):1048\u20131055."},{"issue":"4","key":"b4","series-title":"Neurosurg Rev","first-page":"615","article-title":"Long-term follow-up of pediatric moyamoya disease treated by combined direct-indirect revascularization surgery: single institute experience with surgical and perioperative management","volume":"39","author":"Rashad S","year":"2016","unstructured":"Rashad S, Fujimura M, Niizuma K, Endo H, Tominaga T. Long-term follow-up of pediatric moyamoya disease treated by combined direct-indirect revascularization surgery: single institute experience with surgical and perioperative management. Neurosurg Rev. 2016;39(4):615\u2013623."},{"issue":"6","key":"b5","series-title":"PLoS One","first-page":"e0130663","article-title":"Adult moyamoya disease: a burden of intracranial stenosis in East Asians?","volume":"10","author":"Bang OY","year":"2015","unstructured":"Bang OY, Ryoo S, Kim SJ,  Adult moyamoya disease: a burden of intracranial stenosis in East Asians? PLoS One. 2015;10(6):e0130663."},{"issue":"6532","key":"b6","series-title":"Nature","first-page":"577","article-title":"Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation","volume":"375","author":"Mukhopadhyay D","year":"1995","unstructured":"Mukhopadhyay D, Tsiokas L, Zhou XM, Foster D, Brugge JS, Sukhatme VP. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature. 1995;375(6532):577\u2013581."},{"issue":"2","key":"b7","series-title":"Nat Med","first-page":"131","article-title":"Leaky vessels? Call Ang1!","volume":"6","author":"Jain RK","year":"2000","unstructured":"Jain RK, Munn LL. Leaky vessels? Call Ang1! Nat Med. 2000;6(2):131\u2013132."},{"issue":"3","key":"b8","series-title":"J Clin Invest","first-page":"341","article-title":"Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma","volume":"103","author":"Tanaka S","year":"1999","unstructured":"Tanaka S, Mori M, Sakamoto Y, Makuuchi M, Sugimachi K, Wands JR. Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma. J Clin Invest. 1999;103(3):341\u2013345."},{"issue":"17","key":"b9","series-title":"Proc Natl Acad Sci U S A","first-page":"11205","article-title":"Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo","volume":"99","author":"Lobov IB","year":"2002","unstructured":"Lobov IB, Brooks PC, Lang RA. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci U S A. 2002;99(17):11205\u201311210."},{"issue":"2","key":"b10","series-title":"Angiogenesis","first-page":"123","article-title":"Identification of a soluble form of the angiopoietin receptor TIE-2 released from endothelial cells and present in human blood","volume":"4","author":"Reusch P","year":"2001","unstructured":"Reusch P, Barleon B, Weindel K,  Identification of a soluble form of the angiopoietin receptor TIE-2 released from endothelial cells and present in human blood. Angiogenesis. 2001;4(2):123\u2013131."},{"issue":"12","key":"b11","series-title":"Arterioscler Thromb Vasc Biol","first-page":"2619","article-title":"VEGF induces Tie2 shedding via a phosphoinositide 3-kinase\/Akt dependent pathway to modulate Tie2 signaling","volume":"27","author":"Findley CM","year":"2007","unstructured":"Findley CM, Cudmore MJ, Ahmed A, Kontos CD. VEGF induces Tie2 shedding via a phosphoinositide 3-kinase\/Akt dependent pathway to modulate Tie2 signaling. Arterioscler Thromb Vasc Biol. 2007;27(12):2619\u20132626."},{"issue":"3","key":"b12","series-title":"J Am Coll Cardiol","first-page":"423","article-title":"Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure","volume":"43","author":"Chong AY","year":"2004","unstructured":"Chong AY, Caine GJ, Freestone B, Blann AD, Lip GY. Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure. J Am Coll Cardiol. 2004;43(3):423\u2013428."},{"issue":"16","key":"b13","series-title":"Circulation","first-page":"2355","article-title":"Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes","volume":"110","author":"Lee KW","year":"2004","unstructured":"Lee KW, Lip GY, Blann AD. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes. Circulation. 2004;110(16):2355\u20132360."},{"key":"b14","series-title":"BioMed Res Int","first-page":"8209313","article-title":"Significance of serum angiopoietin-2 in patients with hemorrhage in adult-onset moyamoya disease","volume":"2020","author":"Yu J","year":"2020","unstructured":"Yu J, Huang K, Pan J, Shen J, Zhan R. Significance of serum angiopoietin-2 in patients with hemorrhage in adult-onset moyamoya disease. BioMed Res Int. 2020;2020:8209313."},{"issue":"4","key":"b15","series-title":"J Cereb Blood Flow Metab","first-page":"1527","article-title":"Autocrine release of angiopoietin-2 mediates cerebrovascular disintegration in Moyamoya disease","volume":"37","author":"Blecharz KG","year":"2017","unstructured":"Blecharz KG, Frey D, Schenkel T,  Autocrine release of angiopoietin-2 mediates cerebrovascular disintegration in Moyamoya disease. J Cereb Blood Flow Metab. 2017;37(4):1527\u20131539."},{"issue":"1","key":"b16","series-title":"Exp Ther Med","first-page":"302","article-title":"Expression of circulating vascular endothelial growth factor-antagonizing cytokines and vascular stabilizing factors prior to and following bypass surgery in patients with moyamoya disease","volume":"8","author":"He J","year":"2014","unstructured":"He J, Wang R, Zhang D, Zhang Y, Zhang Q, Zhao J. Expression of circulating vascular endothelial growth factor-antagonizing cytokines and vascular stabilizing factors prior to and following bypass surgery in patients with moyamoya disease. Exp Ther Med. 2014;8(1):302\u2013308."},{"issue":"6","key":"b17","series-title":"J Neurol Neurosurg Psychiatry","first-page":"673","article-title":"Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease","volume":"81","author":"Kang HS","year":"2010","unstructured":"Kang HS, Kim JH, Phi JH,  Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. J Neurol Neurosurg Psychiatry. 2010;81(6):673\u2013678."},{"issue":"2","key":"b18","series-title":"Stroke","first-page":"432","article-title":"Increased levels of circulating endothelial progenitor cells in patients with moyamoya disease","volume":"40","author":"Rafat N","year":"2009","unstructured":"Rafat N, Beck GCh, Pe\u00f1a-Tapia PG, Schmiedek P, Vajkoczy P. Increased levels of circulating endothelial progenitor cells in patients with moyamoya disease. Stroke. 2009;40(2):432\u2013438."},{"issue":"9596","key":"b19","series-title":"Lancet","first-page":"1453","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm E","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20131457."},{"issue":"5","key":"b20","series-title":"Neurol Med Chir (Tokyo)","first-page":"245","article-title":"Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis)","volume":"52","year":"2012","unstructured":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo). 2012;52(5):245\u2013266."},{"issue":"3","key":"b21","series-title":"Arch Neurol","first-page":"288","article-title":"Cerebrovascular \"moyamoya\" disease. Disease showing abnormal net-like vessels in base of brain","volume":"20","author":"Suzuki J","year":"1969","unstructured":"Suzuki J, Takaku A. Cerebrovascular \"moyamoya\" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20(3):288\u2013299."},{"issue":"5","key":"b22","series-title":"J Neurosurg","first-page":"1347","article-title":"A flow self-regulating superficial temporal artery-middle cerebral artery bypass based on side-to-side anastomosis for adult patients with moyamoya disease","volume":"138","author":"Zhang J","year":"2023","unstructured":"Zhang J, Yu J, Xin C,  A flow self-regulating superficial temporal artery-middle cerebral artery bypass based on side-to-side anastomosis for adult patients with moyamoya disease. J Neurosurg. 2023;138(5):1347\u20131356."},{"issue":"3","key":"b23","series-title":"Neurosurgery","first-page":"401","article-title":"Surgical treatment of moyamoya disease in pediatric patients\u2014comparison between the results of indirect and direct revascularization procedures","volume":"31","author":"Matsushima T","year":"1992","unstructured":"Matsushima T, Inoue T, Suzuki SO, Fujii K, Fukui M, Hasuo K. Surgical treatment of moyamoya disease in pediatric patients\u2014comparison between the results of indirect and direct revascularization procedures. Neurosurgery. 1992;31(3):401\u2013405."},{"key":"b24","series-title":"Front Mol Neurosci","first-page":"881954","article-title":"Transcriptomic profiling of intracranial arteries in adult patients with moyamoya disease reveals novel insights into its pathogenesis","volume":"15","author":"Xu S","year":"2022","unstructured":"Xu S, Wei W, Zhang F,  Transcriptomic profiling of intracranial arteries in adult patients with moyamoya disease reveals novel insights into its pathogenesis. Front Mol Neurosci. 2022;15:881954."},{"issue":"4","key":"b25","series-title":"Acta Neurochir (Wien)","first-page":"421","article-title":"Steno-occlusive changes in the external carotid system in moyamoya disease","volume":"142","author":"Komiyama M","year":"2000","unstructured":"Komiyama M, Nishikawa M, Yasui T, Kitano S, Sakamoto H, Fu Y. Steno-occlusive changes in the external carotid system in moyamoya disease. Acta Neurochir (Wien). 2000;142(4):421\u2013424."},{"issue":"1","key":"b26","series-title":"AJR Am J Roentgenol","first-page":"119","article-title":"Prevalence of stenoocclusive lesions in the renal and abdominal arteries in moyamoya disease","volume":"183","author":"Togao O","year":"2004","unstructured":"Togao O, Mihara F, Yoshiura T,  Prevalence of stenoocclusive lesions in the renal and abdominal arteries in moyamoya disease. AJR Am J Roentgenol. 2004;183(1):119\u2013122."},{"issue":"5449","key":"b27","series-title":"Science","first-page":"2511","article-title":"Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1","volume":"286","author":"Thurston G","year":"1999","unstructured":"Thurston G, Suri C, Smith K,  Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science. 1999;286(5449):2511\u20132514."},{"issue":"5322","key":"b28","series-title":"Science","first-page":"55","article-title":"Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis","volume":"277","author":"Maisonpierre PC","year":"1997","unstructured":"Maisonpierre PC, Suri C, Jones PF,  Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 1997;277(5322):55\u201360."},{"issue":"12","key":"b29","series-title":"Proc Natl Acad Sci U S A","first-page":"8219","article-title":"Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF)","volume":"99","author":"Visconti RP","year":"2002","unstructured":"Visconti RP, Richardson CD, Sato TN. Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF). Proc Natl Acad Sci U S A. 2002;99(12):8219\u20138224."},{"issue":"5","key":"b30","series-title":"J Neurosurg","first-page":"882","article-title":"Enhanced brain angiogenesis in chronic cerebral hypoperfusion after administration of plasmid human vascular endothelial growth factor in combination with indirect vasoreconstructive surgery","volume":"103","author":"Kusaka N","year":"2005","unstructured":"Kusaka N, Sugiu K, Tokunaga K,  Enhanced brain angiogenesis in chronic cerebral hypoperfusion after administration of plasmid human vascular endothelial growth factor in combination with indirect vasoreconstructive surgery. J Neurosurg. 2005;103(5):882\u2013890."},{"issue":"4","key":"b31","series-title":"J Neurosurg","first-page":"623","article-title":"Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease","volume":"89","author":"Hojo M","year":"1998","unstructured":"Hojo M, Hoshimaru M, Miyamoto S,  Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease. J Neurosurg. 1998;89(4):623\u2013629."},{"issue":"11","key":"b32","series-title":"PLoS One","first-page":"e0241484","article-title":"High expression of Tie-2 predicts poor prognosis in primary high grade serous ovarian cancer","volume":"15","author":"Sopo M","year":"2020","unstructured":"Sopo M, Sallinen H, H\u00e4m\u00e4l\u00e4inen K,  High expression of Tie-2 predicts poor prognosis in primary high grade serous ovarian cancer. PLoS One. 2020;15(11):e0241484."},{"issue":"1","key":"b33","series-title":"Nat Commun","first-page":"4672","article-title":"Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer","volume":"9","author":"Jayson GC","year":"2018","unstructured":"Jayson GC, Zhou C, Backen A,  Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer. Nat Commun. 2018;9(1):4672."},{"issue":"6","key":"b34","series-title":"J Korean Neurosurg Soc","first-page":"415","article-title":"Moyamoya Biomarkers","volume":"57","author":"Smith ER","year":"2015","unstructured":"Smith ER. Moyamoya Biomarkers. J Korean Neurosurg Soc. 2015;57(6):415\u2013421."},{"key":"b35","series-title":"Front Neurol","first-page":"661952","article-title":"Non-invasive urinary biomarkers in moyamoya disease","volume":"12","author":"Sesen J","year":"2021","unstructured":"Sesen J, Driscoll J, Moses-Gardner A, Orbach DB, Zurakowski D, Smith ER. Non-invasive urinary biomarkers in moyamoya disease. Front Neurol. 2021;12:661952."},{"key":"b36","series-title":"Front Neurol","first-page":"899470","article-title":"TGF\u03b21 as a predictive biomarker for collateral formation within ischemic moyamoya disease","volume":"13","author":"Chen Y","year":"2022","unstructured":"Chen Y, Tang M, Li H, Liu H, Wang J, Huang J. TGF\u03b21 as a predictive biomarker for collateral formation within ischemic moyamoya disease. Front Neurol. 2022;13:899470."},{"issue":"3","key":"b37","series-title":"Neurosurg Rev","first-page":"2305","article-title":"Impact of RNF213 founder polymorphism (p.R4810K) on the postoperative development of indirect pial synangiosis after direct\/indirect combined revascularization surgery for adult Moyamoya disease","volume":"45","author":"Ito M","year":"2022","unstructured":"Ito M, Kawabori M, Sugiyama T,  Impact of RNF213 founder polymorphism (p.R4810K) on the postoperative development of indirect pial synangiosis after direct\/indirect combined revascularization surgery for adult Moyamoya disease. Neurosurg Rev. 2022;45(3):2305\u20132313."},{"issue":"2","key":"b38","series-title":"Cerebrovasc Dis","first-page":"171","article-title":"Impact of RNF213 c.14576G>A variant on the development of direct and indirect revascularization in pediatric moyamoya disease","volume":"52","author":"Kawabori M","year":"2023","unstructured":"Kawabori M, Ito M, Kazumata K,  Impact of RNF213 c.14576G>A variant on the development of direct and indirect revascularization in pediatric moyamoya disease. Cerebrovasc Dis. 2023;52(2):171\u2013176."},{"issue":"4","key":"b39","series-title":"J Neurosurg Pediatr","first-page":"458","article-title":"Ivy sign: a diagnostic and prognostic biomarker for pediatric moyamoya","volume":"29","author":"Montaser AS","year":"2021","unstructured":"Montaser AS, Lalgudi Srinivasan H, Staffa SJ,  Ivy sign: a diagnostic and prognostic biomarker for pediatric moyamoya. J Neurosurg Pediatr. 2021;29(4):458\u2013466."},{"issue":"2","key":"b40","series-title":"Transl Stroke Res","first-page":"357","article-title":"Endothelial progenitor cells induce angiogenesis: a potential mechanism underlying neovascularization in encephaloduroarteriosynangiosis","volume":"12","author":"Wang QN","year":"2021","unstructured":"Wang QN, Zou ZX, Wang XP,  Endothelial progenitor cells induce angiogenesis: a potential mechanism underlying neovascularization in encephaloduroarteriosynangiosis. Transl Stroke Res. 2021;12(2):357\u2013365."},{"issue":"8","key":"b41","series-title":"CNS Neurosci Ther","first-page":"908","article-title":"Use of a panel of four microRNAs in CSF as a predicted biomarker for postoperative neoangiogenesis in moyamoya disease","volume":"27","author":"Wang G","year":"2021","unstructured":"Wang G, Wen Y, Chen S,  Use of a panel of four microRNAs in CSF as a predicted biomarker for postoperative neoangiogenesis in moyamoya disease. CNS Neurosci Ther. 2021;27(8):908\u2013918."}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/139\/6\/article-p1705.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/139\/6\/article-p1705.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/139\/6\/article-p1705.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T10:44:19Z","timestamp":1716029059000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/139\/6\/article-p1705.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":41,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.3171\/2023.4.jns23479","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,1]]}}}